甲状腺髓样癌成功分子成像的不断演变的范式。 - Suppr

Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma.

作者信息

Rubello Domenico, Wong Ka Kit, Marzola Maria Cristina, Beheshti Mohsen, Ambrosini Valentina, Chondrogiannis Sotirios, Gross Milton D

出版信息

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):563-8. doi: 10.1007/s00259-011-2035-2.

DOI:10.1007/s00259-011-2035-2

PMID:22218878

Abstract

摘要

相似文献

Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma.甲状腺髓样癌成功分子成像的不断演变的范式。

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):563-8. doi: 10.1007/s00259-011-2035-2.

Can injection of pentagastrin stimulate the identification of metastases of medullary thyroid carcinoma by (18)F-FDG PET/CT?注射五肽胃泌素能否通过(18)F-FDG PET/CT促进甲状腺髓样癌转移灶的识别？

Hell J Nucl Med. 2012 May-Aug;15(2):155-6. doi: 10.1967/s002449910035. Epub 2012 Jun 27.

Visualization of Lymph Nodal and Hepatic Metastases of Medullary Thyroid Carcinoma on 18F-Fluoride PET/CT.18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对甲状腺髓样癌淋巴结和肝转移的可视化。

Clin Nucl Med. 2015 Nov;40(11):895-6. doi: 10.1097/RLU.0000000000000939.

Diagnosis of small medullary thyroid carcinoma via PET/ultrasound (US) fusion.

Jpn J Clin Oncol. 2014 Mar;44(3):300-1. doi: 10.1093/jjco/hyt175.

SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?甲状腺髓样癌的SPECT/CT和PET/CT分子成像。我们是否走在正确的方向上？

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1692-1694. doi: 10.1007/s00259-017-3757-6. Epub 2017 Jun 22.

¹⁸F-FDG and new positron emitter radiotracers for detecting recurrent medullary thyroid carcinoma.¹⁸F-FDG及用于检测复发性甲状腺髓样癌的新型正电子发射体放射性示踪剂。

J Med Imaging Radiat Oncol. 2012 Apr;56(2):132-5. doi: 10.1111/j.1754-9485.2012.02353.x.

68Ga DOTANOC PET/CT detects medullary thyroid cancer relapse at bone level.68Ga DOTANOC PET/CT 可检测到骨髓甲状腺癌在骨水平的复发。

Clin Nucl Med. 2012 Jun;37(6):591-2. doi: 10.1097/RLU.0b013e31824c5eab.

Molecular imaging for neuroendocrine tumours.神经内分泌肿瘤的分子成像

Swiss Med Wkly. 2019 Mar 10;149:w20017. doi: 10.4414/smw.2019.20017. eCollection 2019 Feb 25.

A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer.

Nucl Med Commun. 2013 Feb;34(2):185-6. doi: 10.1097/MNM.0b013e32835afb67.

Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.18F-FDOPA PET/CT 研究发现散发性甲状腺髓样癌患者回肠末端神经内分泌偶发瘤。

Clin Nucl Med. 2012 Aug;37(8):e206-8. doi: 10.1097/RLU.0b013e31824c5e04.

引用本文的文献

SPECT/CT and PET/CT molecular imaging in medullary thyroid carcinoma. Are we running in the right direction?甲状腺髓样癌的SPECT/CT和PET/CT分子成像。我们是否走在正确的方向上？

Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1692-1694. doi: 10.1007/s00259-017-3757-6. Epub 2017 Jun 22.

The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.2015年修订版美国甲状腺协会髓样甲状腺癌管理指南：欧洲核医学协会因核医学作用被“非循证”边缘化而“循证”拒绝认可这些指南。

Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1486-90. doi: 10.1007/s00259-016-3404-7. Epub 2016 Apr 27.

本文引用的文献

Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.18F-DOPA PET/CT 和 18F-FDG PET/CT 在甲状腺髓样癌中的互补作用。

J Nucl Med. 2011 Dec;52(12):1855-63. doi: 10.2967/jnumed.111.094771. Epub 2011 Nov 3.

Multikinase inhibitors: a new option for the treatment of thyroid cancer.多激酶抑制剂：甲状腺癌治疗的新选择。

Nat Rev Endocrinol. 2011 Aug 23;7(10):617-24. doi: 10.1038/nrendo.2011.141.

Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer.靶向系统放疗治疗嗜铬细胞瘤和甲状腺髓样癌。

Semin Nucl Med. 2011 Sep;41(5):369-73. doi: 10.1053/j.semnuclmed.2011.05.004.

Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers.正电子发射断层扫描/计算机断层扫描在肾上腺和神经内分泌肿瘤中的作用：氟脱氧葡萄糖及非氟脱氧葡萄糖示踪剂

Nucl Med Commun. 2011 Sep;32(9):764-81. doi: 10.1097/MNM.0b013e3283478a2a.

How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer.如何处理信号？当前以RET基因分型为导向选择激酶抑制剂治疗甲状腺髓样癌的依据。

J Thyroid Res. 2011;2011:678357. doi: 10.4061/2011/678357. Epub 2011 Jun 23.

Updates in the management of medullary thyroid cancer.甲状腺髓样癌治疗进展

Clin Adv Hematol Oncol. 2011 May;9(5):391-4.

[Detection by SPECT-CT scan with (99m)Tc-(V) DMSA of bone metastases in patient with medullary thyroid cancer].

Rev Esp Med Nucl. 2011 Nov-Dec;30(6):365-7. doi: 10.1016/j.remn.2010.11.005. Epub 2011 Mar 27.

Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.联合 RET 和 Ki-67 评估在散发性甲状腺髓样癌中的作用：一种用于患者风险分层的有用工具。

Eur J Endocrinol. 2011 Jun;164(6):971-6. doi: 10.1530/EJE-11-0079. Epub 2011 Mar 21.

Alternative therapeutic approaches in the treatment of primary and secondary dedifferentiated and medullary thyroid carcinoma.分化型和髓样甲状腺癌原发和继发去分化治疗的替代治疗方法。

Semin Nucl Med. 2011 Mar;41(2):139-48. doi: 10.1053/j.semnuclmed.2010.10.005.

Metabolic imaging allows early prediction of response to vandetanib.代谢成像可早期预测凡德他尼的应答反应。

J Nucl Med. 2011 Feb;52(2):231-40. doi: 10.2967/jnumed.110.081745. Epub 2011 Jan 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献